T, I., K, T., D, T., E, M., R, S., T, T., . . . T, T. (2025). Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors. Cancer genomics & proteomics, 22(1), 1. https://doi.org/10.21873/cgp.20481
Chicago Style (17th ed.) CitationT, Ishiguro, et al. "Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors." Cancer Genomics & Proteomics 22, no. 1 (2025): 1. https://doi.org/10.21873/cgp.20481.
MLA (9th ed.) CitationT, Ishiguro, et al. "Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors." Cancer Genomics & Proteomics, vol. 22, no. 1, 2025, p. 1, https://doi.org/10.21873/cgp.20481.